Actinium Pharmaceuticals ATNM Growth Metrics (2010-2026)

NYSE ATNM
$1.14 -0.04 (-3.39%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Actinium Pharmaceuticals Quarterly Growth Metrics

Periods 59 quarters
Latest Jun 2026

Actinium Pharmaceuticals growth metrics data for the quarter ended Jun 2026. These growth metrics cover 59 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2010 Dec2011 Mar2012 Jun2012 Sep2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
0.03M-1.52M-1.86M
EBITDA Margin Growth (3y)
1.52M
EBITDA Margin Growth (5y)
0.19M
EBITDA Margin (QoQ)
-0.09M-3.17M3.39M-1.65M-0.42M
EBIT Margin Growth (1y)
0.03M-1.55M-1.90M
EBIT Margin Growth (3y)
1.55M
EBIT Margin Growth (5y)
0.20M
EBIT Margin (QoQ)
-0.09M-3.22M3.44M-1.69M-0.43M
EBT Margin Growth (1y)
0.03M-1.55M-1.90M
EBT Margin Growth (3y)
1.61M
EBT Margin Growth (5y)
0.20M
EBT Margin (QoQ)
-0.09M-3.22M3.44M-1.69M-0.43M
FCF Margin Growth (1y)
0.03M6.32M-1.04M
FCF Margin Growth (3y)
0.58M
FCF Margin Growth (5y)
0.17M
FCF Margin (QoQ)
-0.07M-1.95M2.13M6.21M-7.43M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Net Margin Growth (1y)
0.03M-1.54M-1.83M
Net Margin Growth (3y)
1.54M
Net Margin Growth (5y)
0.20M
Net Margin (QoQ)
-0.09M-3.21M3.43M-1.67M-0.38M
Operating Margin Growth (1y)
0.03M-1.55M-1.90M
Operating Margin Growth (3y)
1.55M
Operating Margin Growth (5y)
0.20M
Operating Margin (QoQ)
-0.09M-3.22M3.44M-1.69M-0.43M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M797.00-84.005.00166.0062.00-568.00-0.00M-0.00M-0.00M-0.00M-24.00703.00984.00-782.00-0.00M-0.00M-0.00M0.00M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.01M0.01M0.01M0.01M0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M-0.00M-0.00M-0.00M0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
51.00-265.00-168.00388.00211.00-369.00-799.00-0.00M-701.00-333.00323.00688.0025.00-52.00-0.00M20.00427.00-473.000.00M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M868.00-134.00-32.00127.0051.00-592.00-0.00M-0.00M-0.00M-0.00M-597.00449.00866.00-988.00-0.00M-0.00M-0.00M0.00M0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.02M0.03M0.02M0.01M0.02M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.01M0.01M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.02M0.02M0.01M0.01M0.02M-0.00M-0.00M-0.00M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
55.00-394.00-148.00454.00214.00-471.00-791.00-0.00M-909.00-573.00270.00614.00137.00-156.00-0.00M-206.00614.00-803.000.00M0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M944.00-144.00-778.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M647.000.00M-0.00M-0.01M-0.01M-0.02M-0.03M0.03M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.01M0.02M0.03M0.02M0.01M0.02M0.04M-636.00-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.03M-0.04M0.02M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.01M0.01M0.02M0.02M0.02M0.01M0.01M0.00M0.00M0.01M0.02M0.01M0.01M0.02M0.04M-0.01M-0.02M-0.03M-0.04M0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
65.00-342.00-233.00-268.00-391.00-826.00-0.00M-0.00M-0.00M-0.00M769.000.00M-253.00-804.00-0.00M-0.00M-0.00M-0.01M-0.01M0.05M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.03M-1.55M-1.90M3.17M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
1.55M-2.35M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
0.20M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.09M-3.22M3.44M-1.69M-0.43M1.85M-2.05M

Actinium Pharmaceuticals Growth Metrics API

Pull Actinium Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ATNM&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY